Evidence map›Paper›PMID 20103957›Full record

GuidelineAnnals of Saudi medicine

Saudi guidelines for testing and treatment of latent tuberculosis infection.

Hamdan H Al Jahdali, Salim Baharoon, Abdullah A Abba, Ziad A Memish, Abdulrahman A Alrajhi, Ali AlBarrak, Qais A Haddad, Mohammad Al Hajjaj, Madhukar Pai, Dick Menzies and 4 more

Open access · diamondAbstract readPractice Guideline
In one paragraph

Guideline in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Hamdan H Al JahdaliDepartment of Medicine, King Saud University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia. jahdali@yahoo.com
Salim Baharoon
Abdullah A Abba
Ziad A Memish
Abdulrahman A Alrajhi
Ali AlBarrak
Qais A Haddad
Mohammad Al Hajjaj
Madhukar Pai
Dick Menzies
Saudi Thoracic Society
Saudi Society of Medical Microbiology and Infectious Disease
Saudi Association of Public Health
Society of Family and Community Medicine
King Saud University · SAKing Abdulaziz Medical City · SAKing Faisal Specialist Hospital & Research Centre · SAKing Khalid University Hospital · SAKing Saud bin Abdulaziz University for Health Sciences · SAMcGill University · CAMontreal Heart Institute · CARiyadh Armed Forces Hospital · SASecurity Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary tuberculosis is a common disease in Saudi Arabia. As most cases of tuberculosis are due to reactivation of latent infection, identification of individuals with latent tuberculosis infection (LTBI) who are at increased risk of progression to active disease, is a key element of tuberculosis control programs. Whereas general screening of individuals for LTBI is not cost-effective, targeted testing of individuals at high risk of disease progression is the right approach. Treatment of those patients with LTBI can diminish the risk of progression to active tuberculosis disease in the majority of treated patients. This statement is the first Saudi guideline for testing and treatment of LTBI and is a result of the cooperative efforts of four local Saudi scientific societies. This Guideline is intended to provide physicians and allied health workers in Saudi Arabia with the standard of care for testing and treatment of LTBI.

Indexed as

Tuberculin TestAntitubercular AgentsDisease ProgressionFalse Negative ReactionsFalse Positive ReactionsHumansSaudi ArabiaTuberculosis, PulmonaryAntitubercular Agents

Identifiers

PMID20103957
PMCPMC2850181
OpenAlexW1978459765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.